RESEARCH ARTICLE
Nobel Med 2016; 12(2): 20-25

RISK OF DEVELOPING SUBCLINICAL HYPOTHYROIDISM AMONG INDIVIDUALS WITH TSH VALUES 2.5-4.2 mIU/L

Tülay Çevlik, Goncagül Haklar, Önder Şirikçi, Kaya Emerk
ABSTRACT
Objective: Estimating the serum thyroid stimulating hormone (TSH) concentration is the most sensitive test to show thyroid function. TSH values of 95 percent of the population fall between 0.3-2.5 mIU/L. Although lower limits of the reference interval is certain, upper limits remains controversial. Research data indicate that individuals with TSH values outside the 2.5-3.0 mIU/L interval are under risk for thyroid disorders. The purpose of this study is to investigate the time dependent subclinical hypothyroidism risk of the individuals with TSH values over 2.5 mIU/L.
Material and Method: The research is composed of three groups including healthy subjects with TSH values between 0.27-2.5 mIU/L (n=55) with negative thyroid peroxidase antibody (TPO Ab) and thyroglobulin antibody (TG Ab) values and cases with TSH values between 2.5-4.2 mIU/L and with positive (60) and negative (n=212) anti-TPO and anti-TG levels. The data are surveyed retrospectively and the difference between the past and present TSH levels are investigated. For statistical analysis paired and unpaired t-test is used.
Results: In all groups statistically meaningful elevation of time dependent TSH values were found. While in the group with TSH values between 2.5-4.2 mIU/L and negative thyroid antibodies the risk of subclinical hypothyroidism was calculated as 23% for the first 5 years, for the group with positive antibodies it was found to be 30%. TSH values 0.27-2.5 mIU/L no subclinical hypothyroidism was evident in 5 years of duration.
Conclusion: The results showed that individuals with TSH values between 2.5-4.2 mIU/L are under risk for subclinical hypothyroid independent of thyroid antibody concentration.

EPILEPSY MANAGEMENT AT WORK ENVIRONMENT: ASPECTS OF OCCUPATIONAL HEALTH AND SAFETY

05-12

Sibel Cevizci, Ethem Erginöz, Handan Işın Özışık Karaman

REVIEW Nobel Med 2016; 12(2): 5-12

MULTIPLE PRIMARY MALIGNANT NEOPLASMS FROM EASTERN BLACK SEA REGION OF TURKEY: SINGLE CENTER EXPERIENCE

13-19

Zümrüt Bahat, Mustafa Kandaz, Yahyahan Memiş, Emine Canyılmaz, Halil Kavgacı, Adnan Yöney

RESEARCH ARTICLE Nobel Med 2016; 12(2): 13-19

RISK OF DEVELOPING SUBCLINICAL HYPOTHYROIDISM AMONG INDIVIDUALS WITH TSH VALUES 2.5-4.2 mIU/L

20-25

Tülay Çevlik, Goncagül Haklar, Önder Şirikçi, Kaya Emerk

RESEARCH ARTICLE Nobel Med 2016; 12(2): 20-25

ASSOCIATION BETWEEN MIGRAINE AND ALLERGIC RHINITIS IN CHILDHOOD AND ADOLESCENCE

26-30

Serhat Güler, Erdal Sakallı, Gözde Yeşil

RESEARCH ARTICLE Nobel Med 2016; 12(2): 26-30

ACUPUNCTURE FOR THE TREATMENT OF MILD OR MODERATE ASTHMA: A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL

31-37

Gülden Bilgin, Hüseyin Arslan, Nurgül Balcı, Didem Sunay

RESEARCH ARTICLE Nobel Med 2016; 12(2): 31-37

THE IMPACT OF hsCRP LEVELS ACROSS GLUCOSE TOLERANCE CATEGORIES: FROM NORMAL GLUCOSE TOLERANCE TO ESTABLISHED DIABETES

38-44

Yıldız Tütüncü, İlhan Satman, Selda Çelik, Bülent Canbaz, Fulya Türker, Nevin Dinççağ, Kubilay Karşıdağ, Ayşegül Telci, Sema Genç, Beyhan Ömer

RESEARCH ARTICLE Nobel Med 2016; 12(2): 38-44

AN ESTIMATION OF IMPAIRED FASTING GLUCOSE PREVALENCE AND RELATED FACTORS: A MIDDLE SCHOOL-BASED STUDY IN CHILDREN AGED 9-16 YEARS

45-52

Sevil İkinci, Seher Nazlı Atak, Ali Rıza Uysal, Serdal Kenan Köse

RESEARCH ARTICLE Nobel Med 2016; 12(2): 45-52

FASTING AND FED BIOEQUIVALENCE STUDIES OF ETODOLAC SUSTAINED RELEASE TABLETS MANUFACTURED IN TURKEY IN HEALTHY VOLUNTEERS

53-59

Abdullah Uslu, İlksen Dikmen, Seda Ünsalan, Berrak Kılınç, Onursal Sağlam, Aydın Erenmemişoğlu, İclal Çakıcı, Ömer Ocak

RESEARCH ARTICLE Nobel Med 2016; 12(2): 53-59

THE EVALUATION OF THE PROCALCITONIN LEVELS IN CHRONIC PROSTATITIS PATIENTS

60-65

Basri Çakıroğlu, Erkan Eyyüpoğlu, Mustafa Bahadır Can Balcı, Aydın İsmet Hazar, Bekir Sami Uyanık, Akif Nuri Doğan

RESEARCH ARTICLE Nobel Med 2016; 12(2): 60-65

INTERFERENCE ON HbA1C MEASUREMENT BY HPLC: HB D

66-68

Mehmet Kalaycı, Hakan Ayyıldız, Mahmut Bozkurt, Mustafa Timurkaan

REPORT Nobel Med 2016; 12(2): 66-68

LONG TERM FOLLOW-UP OF FIVE PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA, CASE BASED CLINICAL STUDY

69-74

Gülbüz Sezgin

REPORT Nobel Med 2016; 12(2): 69-74

ANESTHETIC MANAGEMENT FOR IMPLANTATION OF TOTAL ARTIFICIAL HEART DEVICE: CASE SERIES

75-79

Cengiz Sahutoğlu, Nursen Karaca, Seden Kocabaş, Fatma Zekiye Askar, Serkan Ertugay, Çağatay Engin, Tahir Yağdı, Mustafa Özbaran

REPORT Nobel Med 2016; 12(2): 75-79

A MACULOPAPULAR AND PUSTULAR RASH FOLLOWED BY ERYTHEMA MULTIFORME IN A PATIENT TREATED WITH HYDROXYCHLOROQUINE

80-82

Hatice Duman, İlteris Oğuz Topal, Kübra Cüre, Emek Kocatürk, Çağlar Çakır

REPORT Nobel Med 2016; 12(2): 80-82

RUPTURED HEPATIC ARTERY ANEURYSMS IN THE SETTING OF POLYARTERITIS NODOSA: BUYING TIME WITH ENDOVASCULAR EMBOLIZATION

83-86

Derya Türeli, İsmet Cengiç, Nazila Arasteh, Fikret Küçükkaya, Feyyaz Baltacıoğlu

REPORT Nobel Med 2016; 12(2): 83-86

ORD. PROF. DR. PHILIPP SCHWARTZ (1894-1977) HIS CONTRIBUTION TO 1933 UNIVERSITY REFORM IN TURKEY AND TO PATHOLOGY

87-90

Arın Namal

A PORTRAIT Nobel Med 2016; 12(2): 87-90

LIVER AND SYSTEMIC DISEASES

05-09

Sebati Özdemir

REVIEW Nobel Med 2013; 9(2): 5-9

AGING KIDNEY: SENESCENCE OR DISEASE?

10-14

Meltem Gürsu, Rümeyza Kazancıoğlu, Savaş Öztürk

REVIEW Nobel Med 2013; 9(2): 10-14

IMPORTANCE OF HOLOTRANSCOBALAMIN (HOLOTC) MEASUREMENTS IN EARLY DIAGNOSIS OF COBALAMIN DEFICIENCY, ESPECIALLY IN PATIENTS WITH BORDERLINE VITAMIN B12 CONCENTRATIONS

15-20

Faruk Sönmezışık, Esma Sürmen Gür, Burak Asıltaş

RESEARCH ARTICLE Nobel Med 2013; 9(2): 15-20

EVALUATION OF PHYSICAL GROWTH IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

21-25

Celalettin Koşan, Oğuzhan Sepetçigil, Atilla Çayır, Avni Kaya, Behzat Özkan

RESEARCH ARTICLE Nobel Med 2013; 9(2): 21-25

COMPARISON OF RISK INDEXES USED IN DETERMINING THE POSTOPERATIVE RESPIRATORY INSUFFICIENCY RISK

26-31

Gülsüm Kavalcı, Cavidan Arar, Alkın Çolak, Nesrin Turan, Cemil Kavalcı

RESEARCH ARTICLE Nobel Med 2013; 9(2): 26-31

THE EVALUATION OF PRENATAL AND ENVIROMENTAL RISK FACTORS IN CHILDREN WITH ASTHMA, ALLERGIC RHINITIS AND BRONCHIAL ASTHMA ABSTRACT

32-37

Mehmet İbrahim Turan, Müferet Ergüven, Mehmet Özdemir

RESEARCH ARTICLE Nobel Med 2013; 9(2): 32-37

REOPERATIONS AND MORBIDITY IN THYROID SURGERY

38-42

Serkan Teksöz, Murat Özcan, Aytül Sargan, Yusuf Bukey, Recep Özgültekin, Ateş Özyeğin

RESEARCH ARTICLE Nobel Med 2013; 9(2): 38-42

EFFECTS OF RAMADAN FASTING ON BLOOD PRESSURE CONTROL, LIPID PROFILE, BRAIN NATRIURETIC PEPTIDE, RENAL FUNCTIONS AND ELECTROLYTE LEVELS IN HYPERTENSIVE PATIENTS TAKING COMBINATION THERAPY

43-46

İbrahim Faruk Aktürk, İsmail Bıyık, Cüneyt Koşaş, Ahmet Arif Yalçın, Mehmet Ertürk, Fatih Uzun

RESEARCH ARTICLE Nobel Med 2013; 9(2): 43-46

MANAGEMENT OF A LARGE OUTBREAK CAUSED BY NOROVIRUS AND CAMPYLOBACTER JEJUNI OCCURRED IN A RURAL AREA IN TURKEY

47-51

İbak Gönen

RESEARCH ARTICLE Nobel Med 2013; 9(2): 47-51

FREQUENT CD99 AND FLI-1 EXPRESSIONS IN DIFFUSE LARGE B-CELL LYMPHOMA AND THEIR ASSOCIATION WITH PROLIFERATIVE AND APOPTOTIC RATES

52-56

Ufuk Berber, İsmail Yılmaz, Tolga Tuncel, Zafer Küçükodacı Aptullah Haholu

RESEARCH ARTICLE Nobel Med 2013; 9(2): 52-56
  • Pubmed Style
    Tülay Çevlik, Goncagül Haklar, Önder Şirikçi, Kaya Emerk. [TSH DEĞERLERİ 2,5-4,2 mIU/L ARALIĞINDA BULUNAN BİREYLERİN SUBKLİNİK HİPOTİROİDİ GELİŞTİRME RİSKİ]. Nobel Med 2016; 12(2): 20-25, Turkish.
  • Web Style
    Tülay Çevlik, Goncagül Haklar, Önder Şirikçi, Kaya Emerk. [TSH DEĞERLERİ 2,5-4,2 mIU/L ARALIĞINDA BULUNAN BİREYLERİN SUBKLİNİK HİPOTİROİDİ GELİŞTİRME RİSKİ]. www.nobelmedicus.com/en/Article.aspx?m=1716 [Access: Mayıs 24, 2021], Turkish.
  • AMA (American Medical Association) Style
    Tülay Çevlik, Goncagül Haklar, Önder Şirikçi, Kaya Emerk. [TSH DEĞERLERİ 2,5-4,2 mIU/L ARALIĞINDA BULUNAN BİREYLERİN SUBKLİNİK HİPOTİROİDİ GELİŞTİRME RİSKİ]. Nobel Med 2016; 12(2): 20-25, Turkish.
  • Vancouver/ICMJE Style
    Tülay Çevlik, Goncagül Haklar, Önder Şirikçi, Kaya Emerk. [TSH DEĞERLERİ 2,5-4,2 mIU/L ARALIĞINDA BULUNAN BİREYLERİN SUBKLİNİK HİPOTİROİDİ GELİŞTİRME RİSKİ]. Nobel Med (2016); 12(2): 20-25, [cited Mayıs 24, 2021], Turkish.
  • Harvard Style
    Tülay Çevlik, Goncagül Haklar, Önder Şirikçi, Kaya Emerk. (2016) [TSH DEĞERLERİ 2,5-4,2 mIU/L ARALIĞINDA BULUNAN BİREYLERİN SUBKLİNİK HİPOTİROİDİ GELİŞTİRME RİSKİ]. Nobel Med, 12(2): 20-25, Turkish.